CLINICAL TRIALS
At Wellness Oncology & Hematology, we strongly believe that clinical trials play an integral role in the advancement of cancer care. Research conducted through medication administration and monitoring allows for greater understanding of the functionality of cancerous cells. Cancer is not a one-size-fits-all disease.
Research has shown that cancerous cells have unique genetic traits that are responsible for the way cancer manifests itself in previously healthy individuals. Unfortunately, far too little is known about what causes certain cancers, why cancer metastasizes in some patients and not in others, and why certain treatments will cure or control some types of cancer in one person, but prove less effective in others.
This is why ongoing research, including clinical trials, are so vitally important. New therapies developed and tested today may have profound, positive results for cancer patients tomorrow, next year or twenty years from now.
To help provide our patients with the latest advancements in the fight against cancer, Wellness Oncology & Hematology participates in a wide range of clinical trials and also monitors the results of clinical trials conducted by colleagues.
Click here to learn about our current clinical trials being conducted under the care of Wellness Oncology & Hematology.
TRIAL PHILOSOPHY
Dr. Ashkan Lashkari, Dr. Omid Shaye and Dr. Christopher Ho are proud to take part in testing and trials to further the strides being made in cancer research, diagnosis, treatment and continuing care. All come from an extremely strong academic background, with an emphasis on the science of discovery. In fact, it is precisely this drive to learn more, to find new ways to help patients on the road to recovery that has truly defined Wellness Oncology & Hematology as a forward thinking Medical Oncology Practice.
We are proud to be in the field of research, and very grateful to those who assist and participate in our trials. This work allows us to examine treatments currently considered to be state-of-the-art, and make improvements so they are even better in the future. Our participation in clinical trials provides us the opportunity to stay at the forefront of cancer research, which ultimately benefits our patients, in addition to benefitting the field of cancer treatment as a whole.
The overall wellness of each patient is always the primary concern of Dr. Shaye, Dr. Lashkari and Dr. Ho. At Wellness Oncology & Hematology, we will explain potential side effects and risks involved with participation in any of our clinical trials. We encourage you to ask plenty of questions before deciding whether or not participation is right for you.
BENEFITS OF CLINICAL TRIALS
Through studies conducted in clinical trials, researchers and doctors are able to better understand the genetic composition of cancer cells. When we study how cancer cells form, we may be able to determine why they have formed and how they may mutate in the future. Armed with this information, new compounds (medications) can be tailor-made to treat the specific type of cancer a person is fighting.
Clinical trials may also be influential in understanding the risk of cancer returning, may serve as an alternative to surgeries, and most of all, may allow doctors to understand the highly individual nature of cancer. Therapies developed through clinical trials may become standard treatment in the future. Novel compounds which are examined and tested in the lab, have the potential to significantly alter the chemical treatment landscape of cancer care for generations.
Certainly, clinical trials can be directly credited for the FDA approval of many cancer-fighting medications that are already saving lives. Through short and long term clinical trials and studies of new treatment options, new regimens in the way we treat cancer are being developed every day.
Clinical trials help everyone focus on forward momentum. Every minute of every day, somewhere, someone is learning something new about cancer.
This information is invaluable in helping us work together in the development of treatments for cancer.
